page_banner

Products

Sitagliptin CAS: 486460-32-6

Short Description:

Catalog Number: XD93423
Cas: 486460-32-6
Molecular Formula: C16H15F6N5O
Molecular Weight: 407.31
Availability: In Stock 
Price:  
Prepack:  
Bulk Pack: Request Quote

 


Product Detail

Product Tags

Catalog Number XD93423
Product Name Sitagliptin
CAS 486460-32-6
Molecular Formula C16H15F6N5O
Molecular Weight 407.31
Storage Details Ambient

 

Product Specification

Appearance White powder
Assay 99% min

 

Sitagliptin is a medication that belongs to a class of drugs called dipeptidyl peptidase-4 (DPP-4) inhibitors. It is primarily used in the management of type 2 diabetes mellitus. Diabetes occurs when the body is unable to properly regulate blood sugar levels, leading to high glucose levels in the blood.Sitagliptin works by inhibiting the DPP-4 enzyme, which is responsible for breaking down incretin hormones. These hormones increase insulin secretion and decrease glucagon production, ultimately leading to more controlled blood sugar levels. By inhibiting the DPP-4 enzyme, sitagliptin allows the incretin hormones to remain active for longer periods, thereby improving blood sugar control.The primary mode of administration for sitagliptin is oral, and it can be taken with or without food. The dosage prescribed by a healthcare professional will depend on individual patient factors, such as the severity of diabetes and other medications being used. It is important to follow the prescribed dosing instructions carefully and not to adjust the dosage without consulting a healthcare provider.Sitagliptin is often used as an adjunct to diet and exercise in the management of type 2 diabetes mellitus. It is most commonly prescribed alongside lifestyle modifications and other antidiabetic medications, such as metformin. By combining different mechanisms of action, such as sitagliptin's DPP-4 inhibition and metformin's improvement of insulin sensitivity, better glycemic control can be achieved.The efficacy of sitagliptin in controlling blood sugar levels has been demonstrated in numerous clinical trials. Studies have shown that it can lower both fasting and postprandial (after-meal) glucose levels, reduce glycated hemoglobin (HbA1c) levels, and improve overall glycemic control.Sitagliptin is generally well-tolerated, with the most common side effects being mild, such as headache, upper respiratory tract infections, and gastrointestinal disturbances like nausea or diarrhea. As with any medication, serious allergic reactions and rare but severe side effects can occur, so it is important to report any unusual or severe symptoms to a healthcare professional promptly.In summary, sitagliptin is a medication used in the management of type 2 diabetes mellitus. As a DPP-4 inhibitor, it helps improve glycemic control by prolonging the activity of incretin hormones. When used alongside lifestyle modifications and other antidiabetic medications, sitagliptin can be an effective tool in controlling blood sugar levels and managing type 2 diabetes. Close monitoring and consultation with a healthcare provider are crucial for optimal outcomes.


  • Previous:
  • Next:

  • Close

    Sitagliptin CAS: 486460-32-6